Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.65 USD | -0.64% | -3.73% | -31.59% |
Apr. 09 | Synaptogenix, Inc. acquired Unknown Stake in Psyga Bio Ltd from Cannasoul Analytics Ltd. | CI |
Apr. 03 | Synaptogenix Plans 1-for-25 Reverse Stock Split; Shares Fall | MT |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 5.54M |
---|---|---|---|---|---|
Net income 2022 | -5M | Net income 2023 | -6M | EV / Sales 2022 | - |
Net cash position 2022 | 37.48M | Net cash position 2023 | 30.1M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.42
x | P/E ratio 2023 |
-0.23
x | Employees | 5 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 97.57% |
1 day | -0.64% | ||
1 week | -3.73% | ||
Current month | -1.90% | ||
1 month | -13.73% | ||
3 months | -6.01% | ||
6 months | -31.37% | ||
Current year | -31.59% |
Managers | Title | Age | Since |
---|---|---|---|
Alan Tuchman
CEO | Chief Executive Officer | 77 | 17-12-31 |
Daniel Alkon
PSD | President | 81 | 20-12-06 |
Robert Weinstein
DFI | Director of Finance/CFO | 64 | 13-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Tuchman
CEO | Chief Executive Officer | 77 | 17-12-31 |
Bruce Bernstein
BRD | Director/Board Member | 60 | 16-11-13 |
Joshua Silverman
CHM | Chairman | 53 | 16-08-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 4.65 | -0.64% | 38,974 |
24-05-07 | 4.68 | -0.64% | 77,711 |
24-05-06 | 4.71 | -7.47% | 57,994 |
24-05-03 | 5.09 | +6.93% | 165,126 |
24-05-02 | 4.76 | -1.45% | 48,696 |
Delayed Quote Nasdaq, May 08, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-31.59% | 5.05M | |
+22.56% | 46.71B | |
-1.51% | 41.52B | |
+48.83% | 41.8B | |
-3.42% | 29.55B | |
+10.13% | 25.78B | |
-20.44% | 19.26B | |
+26.45% | 11.98B | |
-0.14% | 12.14B | |
-0.47% | 12.08B |
- Stock Market
- Equities
- SNPX Stock